Dr John Conibear graduated from the University Hospital of Wales in 2001 and completed his post-graduate general medical training in The Barts and The London Training rotation in 2006.
Dr Conibear is currently deputy medical director of St. Bartholomew’s Hospital, the lead for chemotherapy and clinical director for thoracic oncology in St. Bartholomew’s Hospital. Alongside this, he is also the centre clinical lead for the GenesisCare radiotherapy department in the Cromwell Hospital. Dr Conibear is also the oncology clinical lead for the RCP National Lung Cancer Audit (NLCA).
Dr Conibear specialises in all the non-surgical treatments for both lung and breast cancers. He has expertise in chemotherapy, biological therapy, immunotherapy, radiotherapy, and state of the art radiotherapy techniques. These advances delivery techniques include deep inspiration breath hold (DIBH) for early breast cancer, Intensity Modulated Radiotherapy (IMRT), Image Guided Radiotherapy (IGRT) and 4D-CT.
Dr Conibear is also trained in using state of the art radiotherapy technologies including the ViewRay MRIdian MRI-guided linac, Accuray Cyberknife and Leksell Icon Gamma Knife. These technologies are used to deliver stereotactic ablative body or brain radiotherapy (SABR / SRS).
Treatments and tests offered by Dr John Conibear at Nuffield Health
Before gaining his substantive post as a consultant clinical oncologist in St. Bartholomew’s Hospital in 2014, he completed a 2-year fellowship with the NCRI Radiotherapy Trials Quality Assurance Group in Mount Vernon Hospital.
During his fellowship he conducted research into techniques to improve clinician target outlining during radiotherapy planning and was subsequently awarded a MD(Res) from UCL in 2018.
Other posts held
- Consultant Clinical Oncologist at Barts Health NHS Trust
Insurers Dr John Conibear works with
Dr John Conibear works with the following private medical insurance providers:
- Aviva Health
- AXA Health
- Vitality Health (Pru Health)
Dr John Conibear does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Dr John Conibear does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Dr John Conibear holds the following paid advisory role(s) either at this hospital or on behalf of Nuffield Health:
John Conibear was appointed, in June 2020, as the Oncology advisor on the National Medical Advisory Group to Nuffield Health at an hourly rate of £350/hr.